Your browser doesn't support javascript.
loading
Benefit of benralizumab treatment in a patient with chronic symptomatic dermographism.
Bergmann, K C; Altrichter, S; Maurer, M.
Affiliation
  • Bergmann KC; Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Altrichter S; Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Maurer M; Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
J Eur Acad Dermatol Venereol ; 33(11): e413-e415, 2019 Nov.
Article in En | MEDLINE | ID: mdl-31140658
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urticaria / Antibodies, Monoclonal, Humanized / Antipruritics Type of study: Diagnostic_studies Limits: Aged / Aged80 / Humans / Male Language: En Journal: J Eur Acad Dermatol Venereol Journal subject: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Year: 2019 Document type: Article Affiliation country: Alemania
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urticaria / Antibodies, Monoclonal, Humanized / Antipruritics Type of study: Diagnostic_studies Limits: Aged / Aged80 / Humans / Male Language: En Journal: J Eur Acad Dermatol Venereol Journal subject: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Year: 2019 Document type: Article Affiliation country: Alemania